StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2023 - 11 - 10
1
2022 - 01 - 21
1
2021 - 09 - 20
1
2021 - 09 - 19
1
Sector
Health technology
4
Tags
Acquired
1
Acquisition
1
Advanced
1
Agreement
2
Alliances
4
America
1
Application
3
Approval
2
Artificial intelligence
1
Asco
2
Authorization
1
Biocapital
1
Biomarkers
2
Bioscience
3
Biotech-beach
12
Biotechnology
3
Breakthrough therapy
1
Cancer
32
Cancer drug
1
Care
2
Cel
1
Cell
4
Collaboration
5
Colorectal cancer
2
Conference
11
Designation
2
Diagnostic
3
Drug
5
Earnings
2
Events
2
Fda
5
Financial
7
Financial results
5
Food
3
Global
3
Grant
6
Health
3
Krasg12
12
Lung
11
Lung cancer
7
N/a
65
Nasdaq
5
New drug
2
Offering
4
Pharm-country
2
Phase 1
2
Positive
4
Report
8
Research
7
Results
25
Sapphire
2
Study
4
System
2
Test
3
Therapeutics
49
Therapy
4
Treatment
9
Tumors
4
Update
3
World
2
Entities
Bristol-myers squibb company
1
Mirati therapeutics, inc.
4
Symbols
ABBV
31
ADIL
10
ALNY
19
ALPMF
14
ALPMY
14
AMGN
14
ANVS
10
AQST
18
ARVL
21
AZN
13
BBIO
16
BGNE
19
BIIB
13
BMY
27
BNTX
17
BYSI
11
CHRS
21
CLDX
10
CLSD
15
DARE
13
FBIO
10
FNCTF
21
GILD
13
GSK
12
HOTH
14
IMMP
12
IMMX
10
INCY
15
IONS
21
IT
12
JNJ
46
LLY
30
LTUM
14
MDWD
11
MRK
19
MS
10
MYOV
10
NDAQ
42
NVS
20
NVSEF
16
PFE
45
PLRX
10
PPRUF
11
PPRUY
11
RCKT
11
RDHL
10
REGN
26
RGNX
17
RNAZ
10
SCYX
11
SLS
11
SNY
103
SNYNF
79
SRNE
19
TAK
15
TAYD
17
TEVJF
14
TNXP
12
VERU
10
VRTX
11
Exchanges
Nasdaq
4
Nyse
1
Crawled Date
2023 - 11 - 10
1
2022 - 01 - 21
1
2021 - 09 - 20
1
2021 - 09 - 19
1
Crawled Time
12:00
1
12:30
1
15:30
1
16:20
1
Source
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
symbols :
MRTX
save search
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Published:
2023-11-10
(Crawled : 12:30)
- prnewswire.com
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-2.82%
|
O:
0.4%
H:
0.18%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.61%
|
O:
-0.11%
H:
0.0%
C:
0.0%
krasg12
lung
chmp
positive
cancer
cell
treatment
therapeutics
Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-Mutated Gastrointestinal Cancers
Published:
2022-01-21
(Crawled : 15:30)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-50.3%
|
O:
-0.33%
H:
0.0%
C:
0.0%
krasg12
gastrointestinal
therapeutics
test
positive
cancer
Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published:
2021-09-20
(Crawled : 12:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-65.56%
|
O:
0.78%
H:
11.36%
C:
3.1%
phase 2
lung cancer
positive
results
cancer
topline
Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib as Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-Mutated Colorectal Cancer
Published:
2021-09-19
(Crawled : 16:20)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
positive
therapy
cancer
colorectal cancer
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.